Indeed, c-MET has been shown to be overexpressed in 26.0%–73.2% of cases of diffuse large B-cell lymphoma (Lam et al., 2016), and to be significantly associated with intracellular signaling pathways (Uddin et al., 2010). Here, MET is linked to diffuse large B-cell lymphoma.